measles
MEASLES
Measles, also known as rubeola, is a highly contagious disease caused by the measles virus Morbillivirus.
It is characterized by generalized maculopapular rash, fever, cough, rhinitis and conjunctivitis. Transmission is through respiratory tract or conjunctivae following contact with droplet aerosols.
It is highly communicable from 4 days before the rash up to 4 days after its onset.
The incubation period from exposure to prodrome averages 7-21 days.

Diagnosis

  • Diagnosis is based on clinical findings in the absence of measles outbreak

Laboratory Tests

  • CBC may reveal leukopenia & lymphopenia, absolute neutropenia may also occur
  • Serologic tests may be used to confirm the diagnosis
    • A single elevated IgM level is indicative of recent infection; IgM antibody appears in 75% of cases w/in 3 days after emergence of rashes, increases up to 100% after 7 days, & remains detectable for about 1-2 mth
    • A 4-fold rise in IgG levels in acute & convalescent specimens may also be used; 1st specimen is drawn soon after the onset of rash, 2nd specimen is taken 10-30 days later

Complications

  • Croup, tracheitis, bronchiolitis, acute otitis media, pneumonia
  • Acute encephalitis
    • May present w/ fever, headache, changes in sensorium; usually occur 2-6 days after the appearance of rash
  • Subacute sclerosing panencephalitis
    • Incubation period of 7-10 yr
    • Result from persistent CNS infection; more likely to develop in males
    • Presents w/ gradual deterioration in intellectual & behavioral function
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Mar 2018
During the Kuala Lumpur International Neonatology Conference held in conjunction with the World Prematurity Day 2017, Dato Dr Musa Mohd Nordin spoke on the importance of immunizing children with the diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine. He highlighted the role of Hexaxim® as a fully liquid, ready-to-use, 6-in-1 (including hepatitis B) vaccine for the primary and booster vaccinations of infants and toddlers. Meanwhile, Dr Yong Junina Fadzil discussed the benefits of quadrivalent influenza vaccines (QIVs) in providing children with broader protection against influenza B viruses.